Douglas Lane & Associates LLC Acquires Shares of 169,977 Grail, Inc. (NASDAQ:GRAL)

Douglas Lane & Associates LLC bought a new position in shares of Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, Holdings Channel reports. The firm bought 169,977 shares of the company’s stock, valued at approximately $3,034,000.

Wall Street Analyst Weigh In

A number of research firms have issued reports on GRAL. Guggenheim assumed coverage on Grail in a research report on Thursday, October 17th. They issued a “neutral” rating for the company. Wolfe Research began coverage on Grail in a report on Friday, November 15th. They issued a “peer perform” rating for the company. Finally, Morgan Stanley began coverage on shares of Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective on the stock.

Grail Stock Down 1.2 %

Grail stock opened at $17.66 on Thursday. The firm has a 50 day simple moving average of $17.80. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $24.92.

Insider Activity

In related news, CEO Robert P. Ragusa sold 123,454 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $14.02, for a total transaction of $1,730,825.08. Following the completion of the transaction, the chief executive officer now owns 612,661 shares of the company’s stock, valued at approximately $8,589,507.22. The trade was a 16.77 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Aaron Freidin sold 30,452 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the completion of the sale, the chief financial officer now owns 268,277 shares in the company, valued at $3,761,243.54. This represents a 10.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.